Search all content on GOV.UK

Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.

• Updated: 29 May 2024

• Updated: 15 September 2021

Epimax Ointment and Epimax Paraffin-Free Ointment can harm the eyes if used on the face. Do not prescribe these ointments for use on the face. Tell patients to wash their hands and avoid touching their eyes after using these products.

• Updated: 23 July 2024

Take care when using creams to treat dry skin conditions as they can easily dry onto clothing, bedding and bandages making them more flammable.

• Updated: 26 May 2021

Topical steroid products are safe and highly effective treatments for the management of a wide range of inflammatory skin diseases but have important risks, especially with prolonged use at high potency. In the coming months, as a result of regulatory...

• Updated: 29 May 2024

Manx Healthcare Ltd. has informed MHRA that they have identified a problem with the product packaging of the batch indicated in the table.

• Updated: 3 June 2024

We are considering making Dovonex Psoriasis 50 microgram/g Ointment available to buy from pharmacies. We always want to involve the public and healthcare professionals in decisions that affect them. We want to know what you think about this change.

• Updated: 17 August 2017

How the MHRA makes decisions on whether a borderline product is a medical device and which risk class should apply.

• Updated: 11 July 2023

These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.

• Updated: 12 March 2025

Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.

• Updated: 22 July 2021